Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
60°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
28
29
Next >
Here's How Much $1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
July 01, 2022
Tickers
REGN
Tags
News
Earnings
Market News
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
July 01, 2022
Tickers
ACER
ALNY
ARQT
BGNE
Tags
Top Stories
XBI
SNY
From
Benzinga
U.S. FDA Accepts Regeneron's Diabetic Retinopathy Candidate Submission For Review
June 29, 2022
Tickers
REGN
Tags
FDA PDUFA Date
Benzinga
FDA
From
Benzinga
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
June 25, 2022
Tickers
REGN
SNY
Tags
SNY
Market News
Recent Press Releases
From
Motley Fool
Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis
June 24, 2022
Tickers
NTLA
REGN
Tags
General
Health Care
REGN
From
Benzinga
Regeneron Pharmaceuticals Whale Trades Spotted
June 17, 2022
Tickers
REGN
Tags
REGN
Benzinga
Options
From
Benzinga
Is Regeneron Absurdly Cheap or Has it Become a Value Trap?
June 16, 2022
Tickers
REGN
SNY
XLV
Tags
SNY
Market News
Recent Press Releases
From
Motley Fool
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,800 Today
June 15, 2022
Tickers
REGN
Tags
News
Market News
Earnings
From
Benzinga
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
June 08, 2022
Tickers
APLS
BCRX
DBVT
EIGR
Tags
APLS
Covid/19
MNOV
From
Benzinga
Sunshine Biopharma States It Is Developing COVID Antiviral That Could Play Important Role In Treating Endemic COVID
June 08, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
Partner Content
General
Sunshine Biopharma
From
Benzinga
U.S. FDA Approves Regeneron And Sanofi's Lead Drug For Skin Inflammation In Children
June 07, 2022
Tickers
REGN
SNY
Tags
REGN
Health Care
General
From
Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
June 05, 2022
Tickers
ACER
ACET
AGLE
ALKS
Tags
FDA
AGLE
BMY
From
Benzinga
Why Regeneron Wasn't a Healthy Stock Today
June 02, 2022
Tickers
REGN
SNY
Tags
Recent Press Releases
REGN
SNY
From
Motley Fool
Markets Rise Amid Strength In Tech, Software
June 02, 2022
Tickers
DIA
DXCM
ENPH
F
Tags
Markets
HRL
SPY
From
Benzinga
Regeneron Pharmaceuticals Whale Trades Spotted
June 02, 2022
Tickers
REGN
Tags
Market News
BZI/UOA
Markets
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
May 31, 2022
Tickers
ACAD
ACER
AMLX
BLUE
Tags
Small Cap
Biotech
MRNA
From
Benzinga
7 Analysts Have This to Say About Regeneron Pharmaceuticals
May 31, 2022
Tickers
REGN
Tags
Benzinga
BZI/AAR
REGN
From
Benzinga
FDA Accepts Regeneron, Sanofi's Filing For Review In Skin Disease
May 31, 2022
Tickers
REGN
SNY
Tags
Movers
News
SNY
From
Benzinga
As COVID Subsidies, Here are 8 Infectious Diseases That Could Emerge As Potent Threats
May 30, 2022
Tickers
IBB
REGN
SIGA
XBI
Tags
Education
XBI
SIGA
From
Benzinga
Why Regeneron Investors Shouldn't Fear Its Patent Cliff
May 26, 2022
Tickers
AMGN
NVS
REGN
SNY
Tags
REGN
Recent Press Releases
NVS
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
May 23, 2022
Tickers
ABBV
ABG
ADSK
AMGN
Tags
UPWK
BZI/Ratings
ATHX
From
Benzinga
Regeneron's Evkeeza Reduces Bad Cholesterol By 48% In Children Aged 5-11 Years
May 23, 2022
Tickers
RARE
REGN
Tags
Biotech
News
Briefs
From
Benzinga
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
May 22, 2022
Tickers
ABBV
BIOC
BLTE
BMY
Tags
Top Stories
Earnings
SNY
From
Benzinga
FDA Approves Regeneron and Sanofi's Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule
May 20, 2022
Tickers
REGN
SNY
Tags
REGN
Health Care
General
From
Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
May 18, 2022
Tickers
ALGN
BCRX
BMRN
BMY
Tags
REGN
DAWN
BMY
From
Benzinga
Regeneron Pharmaceuticals Earnings Perspective: Return On Capital Employed
May 16, 2022
Tickers
REGN
Tags
Benzinga
REGN
Earnings
From
Benzinga
Is Regeneron In Trouble After Sales Declined 40% In a Single Quarter?
May 12, 2022
Tickers
REGN
Tags
Market News
REGN
Recent Press Releases
From
Motley Fool
$1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much
May 04, 2022
Tickers
REGN
Tags
Benzinga
Dividends
BZI/POD
From
Benzinga
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
May 04, 2022
Tickers
AGTC
ALLO
ALNA
AMRN
Tags
FATE
FDA
Financing
From
Benzinga
Regeneron Pharmaceuticals: Q1 Earnings Insights
May 04, 2022
Tickers
REGN
Tags
Earnings
Market News
BZI/Recaps
From
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.